Alfaiate Dulce, Lucifora Julie, Abeywickrama-Samarakoon Natali, Michelet Maud, Testoni Barbara, Cortay Jean-Claude, Sureau Camille, Zoulim Fabien, Dény Paul, Durantel David
INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon (CRCL), 69008 Lyon, France; University of Lyon, Université Claude-Bernard (UCBL), 69008 Lyon, France.
INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon (CRCL), 69008 Lyon, France; University of Lyon, Université Claude-Bernard (UCBL), 69008 Lyon, France.
Antiviral Res. 2016 Dec;136:19-31. doi: 10.1016/j.antiviral.2016.10.006. Epub 2016 Oct 19.
Hepatitis D virus (HDV) super-infection of Hepatitis B virus (HBV)-infected patients is the most aggressive form of viral hepatitis. HDV infection is not susceptible to direct anti-HBV drugs, and only suboptimal antiviral responses are obtained with interferon (IFN)-alpha-based therapy. To get insights on HDV replication and interplay with HBV in physiologically relevant hepatocytes, differentiated HepaRG (dHepaRG) cells, previously infected or not with HBV, were infected with HDV, and viral markers were extensively analyzed. Innate and IFN responses to HDV were monitored by measuring pro-inflammatory and interferon-stimulated gene (ISG) expression. Both mono- and super-infected dHepaRG cells supported a strong HDV intracellular replication, which was accompanied by a strong secretion of infectious HDV virions only in the super-infection setting and despite the low number of co-infected cells. Upon HDV super-infection, HBV replication markers including HBeAg, total HBV-DNA and pregenomic RNA were significantly decreased, confirming the interference of HDV on HBV. Yet, no decrease of circular covalently closed HBV DNA (cccDNA) and HBsAg levels was evidenced. At the peak of HDV-RNA accumulation and onset of interference on HBV replication, a strong type-I IFN response was observed, with interferon stimulated genes, RSAD2 (Viperin) and IFI78 (MxA) being highly induced. We established a cellular model to characterize in more detail the direct interference of HBV and HDV, and the indirect interplay between the two viruses via innate immune responses. This model will be instrumental to assess molecular and immunological mechanisms of this viral interference.
乙型肝炎病毒(HBV)感染患者的丁型肝炎病毒(HDV)重叠感染是病毒性肝炎中最具侵袭性的形式。HDV感染对直接抗HBV药物不敏感,基于α干扰素(IFN)的治疗仅能获得次优的抗病毒反应。为了深入了解HDV在生理相关肝细胞中的复制以及与HBV的相互作用,将先前感染或未感染HBV的分化HepaRG(dHepaRG)细胞感染HDV,并对病毒标志物进行了广泛分析。通过测量促炎和干扰素刺激基因(ISG)的表达来监测对HDV的固有免疫和干扰素反应。单感染和重叠感染的dHepaRG细胞均支持HDV在细胞内的强力复制,仅在重叠感染情况下伴随着传染性HDV病毒粒子的强力分泌,尽管共感染细胞数量较少。HDV重叠感染后,包括HBeAg、总HBV-DNA和前基因组RNA在内的HBV复制标志物显著降低,证实了HDV对HBV的干扰。然而,未发现共价闭合环状HBV DNA(cccDNA)和HBsAg水平降低。在HDV-RNA积累的高峰期以及对HBV复制产生干扰时,观察到强烈的I型干扰素反应,干扰素刺激基因RSAD2(Viperin)和IFI78(MxA)被高度诱导。我们建立了一个细胞模型,以更详细地描述HBV和HDV的直接干扰以及两种病毒通过固有免疫反应的间接相互作用。该模型将有助于评估这种病毒干扰的分子和免疫机制。